Core Viewpoint - Quantum BioPharma Ltd. announced the publication of a clinical trial demonstrating that its dietary supplement 'unbuzzd' significantly accelerates alcohol metabolism, reduces blood alcohol concentration (BAC), and alleviates symptoms of intoxication and hangover [1][7]. Clinical Trial Findings - The clinical trial was a double-blind, randomized, placebo-controlled study involving healthy participants aged 21 to 43, who consumed alcohol to achieve a BAC between 0.07% and 0.11% before taking either unbuzzd or a placebo [2]. - unbuzzd reduced BAC by more than 40% faster within the first 30 minutes compared to placebo, with continued acceleration observed over a four-hour period [5]. - Participants reported significant improvements in alertness within 30 minutes of consuming unbuzzd, outperforming placebo results [6]. - The supplement stabilized heart rate and blood pressure, which are typically elevated during alcohol intoxication, with these results being statistically significant [6]. - Participants experienced a statistically significant reduction in hangover symptoms, including a 67% reduction in headache severity at four and eight hours post-consumption [6]. Product Information - unbuzzd is a dietary supplement developed by a team of scientists at Quantum BioPharma, comprising a proprietary blend of vitamins and supplements [1][9]. - The product is available for purchase through its website and on Amazon, with various packaging options [10]. - Quantum BioPharma retains a 19.86% ownership stake in Unbuzzd Wellness Inc., which markets unbuzzd, and is entitled to a 7% royalty on sales until reaching $250 million, after which the royalty will drop to 3% [12].

Core Viewpoint - Quantum BioPharma Ltd. announces a $5 million fundraising initiative through its licensee Unbuzzd Wellness Inc., which offers a scientifically-backed beverage aimed at enhancing alcohol metabolism and reducing hangover symptoms, without diluting existing shareholders [1][3]. Company Overview - Quantum BioPharma is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders [1][7]. - Unbuzzd Wellness Inc. is a public issuer that specializes in wellness and recovery supplements, particularly a beverage designed to aid in alcohol metabolism and cognitive recovery [4][7]. Product Details - Unbuzzd is a beverage that accelerates alcohol metabolism, restores mental clarity, and alleviates hangover symptoms, developed by a team of experts in pharmacology and medicine [4][5]. - The product has undergone a clinical trial demonstrating significant efficacy, including a more than 40% faster reduction in blood alcohol concentration (BAC) within 30 minutes compared to control subjects [5]. Clinical Trial Findings - Key findings from the clinical trial include: - Accelerated alcohol metabolism with a significant reduction in BAC [5]. - Statistically significant improvements in alertness and cognitive performance within 30 minutes of consumption [5]. - Stabilization of heart rate and blood pressure during alcohol intoxication [5]. - Notable reduction in hangover symptoms, including a 67% reduction in headache severity at four hours post-consumption [5][6]. - Unbuzzd was well-tolerated with no reported adverse side effects [6]. Investment Opportunity - Unbuzzd is hosting an investor webinar to discuss the investment opportunity related to its beverage and plans for scaling distribution and retail sales [2][3]. - The company aims to raise up to $5 million to support its expansion plans and potentially pave the way for an initial public offering [3]. Ownership and Financial Structure - Quantum BioPharma retains a 20.10% ownership stake in Unbuzzd Wellness Inc. and is entitled to a 7% royalty on sales until reaching $250 million, after which the royalty will decrease to 3% [7].